IHA Hematology Oncology Consultants-Brighton — Brighton, Michigan

IHA Hematology Oncology Consultants-Brighton is a clinical research site located in Brighton, Michigan, United States 48114.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

IHA Hematology Oncology Consultants-Brighton has participated in 46 clinical trials with 14 currently active.

Therapeutic areas: Myelodysplastic Syndromes (MDS), Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma.

Sponsors: National Heart, Lung, and Blood Institute (NHLBI), GOG Foundation, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Brighton

Browse all research sites in Michigan · View every site in Brighton

• University of Michigan Health System
• Saint Joseph Mercy Hospital - Brighton
• University of Michigan / Brighton Health Center
• University of Michigan Brighton Center for Specialty Care
• University of Michigan
• University of Michigan (Michigan Medicine)-Brighton Health Center
• Trinity Health IHA Medical Group Hematology Oncology-Brighton
• Trinity Health Medical Center-Brighton
• Saint Joseph Mercy Brighton
• Brighton Center for Specialty Care
• Michigan Arthritis Research Center

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IHA Hematology Oncology Consultants-Brighton?

IHA Hematology Oncology Consultants-Brighton has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IHA Hematology Oncology Consultants-Brighton conducted?

IHA Hematology Oncology Consultants-Brighton has 46 clinical trials on record, with 14 currently active. Their work covers Myelodysplastic Syndromes (MDS), Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma.

Is IHA Hematology Oncology Consultants-Brighton accredited by Crixeo Clinical Trials?

IHA Hematology Oncology Consultants-Brighton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IHA Hematology Oncology Consultants-Brighton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.